Cargando…
Comparable Post-Vaccination Decay of Neutralizing Antibody Response to Wild-Type and Delta SARS-CoV-2 Variant in Healthcare Workers Recovered from Mild or Asymptomatic Infection
We described the long-term decay of neutralizing antibody (NtAb) to the wild-type and Delta SARS-CoV-2 variant after three antigen stimulations (mild or asymptomatic natural infection followed by two doses of the BNT162b2 mRNA vaccine after a median of 296 days) in immunocompetent healthcare workers...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9025891/ https://www.ncbi.nlm.nih.gov/pubmed/35455329 http://dx.doi.org/10.3390/vaccines10040580 |
_version_ | 1784690987313922048 |
---|---|
author | Vicenti, Ilaria Basso, Monica Dragoni, Filippo Gatti, Francesca Scaggiante, Renzo Fiaschi, Lia Parisi, Saverio G. Zazzi, Maurizio |
author_facet | Vicenti, Ilaria Basso, Monica Dragoni, Filippo Gatti, Francesca Scaggiante, Renzo Fiaschi, Lia Parisi, Saverio G. Zazzi, Maurizio |
author_sort | Vicenti, Ilaria |
collection | PubMed |
description | We described the long-term decay of neutralizing antibody (NtAb) to the wild-type and Delta SARS-CoV-2 variant after three antigen stimulations (mild or asymptomatic natural infection followed by two doses of the BNT162b2 mRNA vaccine after a median of 296 days) in immunocompetent healthcare workers (HCWs). Live virus microneutralization against the B.1 and Delta SARS-CoV-2 variants was performed in VERO E6 cell cultures. The median NtAb titers for B.1 and Delta were comparable and highly correlated at both 20 and 200 days after the second vaccine dose in the 23 HCWs enrolled (median age, 46 years). A small group of naturally infected unvaccinated HCWs had comparable NtAb titers for the two strains after a median follow-up of 522 days from infection diagnosis. The NtAb response to the Delta VoC appears to follow the same long-term dynamics as the wild-type response regardless of the vaccinal boost; data collected after three antigen stimulations (natural infection followed by two doses of the BNT162b2 mRNA vaccine) may be helpful for tailoring the continuous monitoring of vaccine protection against SARS-CoV-2 variants over time. |
format | Online Article Text |
id | pubmed-9025891 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-90258912022-04-23 Comparable Post-Vaccination Decay of Neutralizing Antibody Response to Wild-Type and Delta SARS-CoV-2 Variant in Healthcare Workers Recovered from Mild or Asymptomatic Infection Vicenti, Ilaria Basso, Monica Dragoni, Filippo Gatti, Francesca Scaggiante, Renzo Fiaschi, Lia Parisi, Saverio G. Zazzi, Maurizio Vaccines (Basel) Communication We described the long-term decay of neutralizing antibody (NtAb) to the wild-type and Delta SARS-CoV-2 variant after three antigen stimulations (mild or asymptomatic natural infection followed by two doses of the BNT162b2 mRNA vaccine after a median of 296 days) in immunocompetent healthcare workers (HCWs). Live virus microneutralization against the B.1 and Delta SARS-CoV-2 variants was performed in VERO E6 cell cultures. The median NtAb titers for B.1 and Delta were comparable and highly correlated at both 20 and 200 days after the second vaccine dose in the 23 HCWs enrolled (median age, 46 years). A small group of naturally infected unvaccinated HCWs had comparable NtAb titers for the two strains after a median follow-up of 522 days from infection diagnosis. The NtAb response to the Delta VoC appears to follow the same long-term dynamics as the wild-type response regardless of the vaccinal boost; data collected after three antigen stimulations (natural infection followed by two doses of the BNT162b2 mRNA vaccine) may be helpful for tailoring the continuous monitoring of vaccine protection against SARS-CoV-2 variants over time. MDPI 2022-04-09 /pmc/articles/PMC9025891/ /pubmed/35455329 http://dx.doi.org/10.3390/vaccines10040580 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Communication Vicenti, Ilaria Basso, Monica Dragoni, Filippo Gatti, Francesca Scaggiante, Renzo Fiaschi, Lia Parisi, Saverio G. Zazzi, Maurizio Comparable Post-Vaccination Decay of Neutralizing Antibody Response to Wild-Type and Delta SARS-CoV-2 Variant in Healthcare Workers Recovered from Mild or Asymptomatic Infection |
title | Comparable Post-Vaccination Decay of Neutralizing Antibody Response to Wild-Type and Delta SARS-CoV-2 Variant in Healthcare Workers Recovered from Mild or Asymptomatic Infection |
title_full | Comparable Post-Vaccination Decay of Neutralizing Antibody Response to Wild-Type and Delta SARS-CoV-2 Variant in Healthcare Workers Recovered from Mild or Asymptomatic Infection |
title_fullStr | Comparable Post-Vaccination Decay of Neutralizing Antibody Response to Wild-Type and Delta SARS-CoV-2 Variant in Healthcare Workers Recovered from Mild or Asymptomatic Infection |
title_full_unstemmed | Comparable Post-Vaccination Decay of Neutralizing Antibody Response to Wild-Type and Delta SARS-CoV-2 Variant in Healthcare Workers Recovered from Mild or Asymptomatic Infection |
title_short | Comparable Post-Vaccination Decay of Neutralizing Antibody Response to Wild-Type and Delta SARS-CoV-2 Variant in Healthcare Workers Recovered from Mild or Asymptomatic Infection |
title_sort | comparable post-vaccination decay of neutralizing antibody response to wild-type and delta sars-cov-2 variant in healthcare workers recovered from mild or asymptomatic infection |
topic | Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9025891/ https://www.ncbi.nlm.nih.gov/pubmed/35455329 http://dx.doi.org/10.3390/vaccines10040580 |
work_keys_str_mv | AT vicentiilaria comparablepostvaccinationdecayofneutralizingantibodyresponsetowildtypeanddeltasarscov2variantinhealthcareworkersrecoveredfrommildorasymptomaticinfection AT bassomonica comparablepostvaccinationdecayofneutralizingantibodyresponsetowildtypeanddeltasarscov2variantinhealthcareworkersrecoveredfrommildorasymptomaticinfection AT dragonifilippo comparablepostvaccinationdecayofneutralizingantibodyresponsetowildtypeanddeltasarscov2variantinhealthcareworkersrecoveredfrommildorasymptomaticinfection AT gattifrancesca comparablepostvaccinationdecayofneutralizingantibodyresponsetowildtypeanddeltasarscov2variantinhealthcareworkersrecoveredfrommildorasymptomaticinfection AT scaggianterenzo comparablepostvaccinationdecayofneutralizingantibodyresponsetowildtypeanddeltasarscov2variantinhealthcareworkersrecoveredfrommildorasymptomaticinfection AT fiaschilia comparablepostvaccinationdecayofneutralizingantibodyresponsetowildtypeanddeltasarscov2variantinhealthcareworkersrecoveredfrommildorasymptomaticinfection AT parisisaveriog comparablepostvaccinationdecayofneutralizingantibodyresponsetowildtypeanddeltasarscov2variantinhealthcareworkersrecoveredfrommildorasymptomaticinfection AT zazzimaurizio comparablepostvaccinationdecayofneutralizingantibodyresponsetowildtypeanddeltasarscov2variantinhealthcareworkersrecoveredfrommildorasymptomaticinfection |